The impact of COVID-19 has made an enormous demand for RNA extraction kits in India and worldwide. The extraordinary demand for RNA extraction kits and COVID-19 polymerase chain reaction (PCR) testing has strained the production capabilities of vendors in the nucleic acid preparation (NA prep) market.
To know the complete strategy and impact of Covid-19 for skyrocketing demand of RNA extraction kits and other RNA isolation kits, feel free to continue reading. Without further ado, let's move onto what does Azooka.life LifeScience Fluorophore startup says about the importance and needs of RNA Extraction kits for Covid19.
Why Need Azooka's RNA Extraction Kit and Not DNA Extraction?
- Isolation high-quality RNA is the most critical step for successfully performing a broad range of research purposes, as well as for any laboratory studies. It is even critical for high-throughput transcriptome analysis using next-generation sequencing techniques and using the RNA and DNA gel stains can be a great way to succeed.
- Compared to DNA, the RNA molecule has a relatively delicate chemical structure and is very susceptible to degradation by ribonuclease (RNase) enzymes. RNase can occur in the air, on surfaces, and in aqueous solutions, making the production of RNase-free reagents and plasticware more challenging for researchers.
- These challenges make it difficult to quickly scale up production or convert production facilities for making RNA extraction consumables than with DNA extraction.
- Thus extraction difficulties are only compounded by the multiple collections of Azooka's RNA purification kits Or RNA extraction kits with any samples.
- However, getting the most from your RNA isolation procedure is a top success for COVID19 issues.
- Also, High-quality experiments require high-quality samples, and maximizing the yield of a non-degraded RNA isolation kit is key.
- How Does Azooka's LifeScience RNA Extraction Kits Works for COVID19?
- SARS-CoV-2, the coronavirus responsible for the COVID-19 illness, encodes its genome in a single-stranded RNA.
- In-vitro diagnostics of COVID-19 are done by quantitative PCR (qPCR), but the first RNA molecule must be extracted from a patient sample and reverse transcribed.
Advantages of Using Azooka's LifeScience RNA Extraction Kits -
- Simple, straightforward procedure to perform.
- A ready to use RNA extraction kit format, which adds convenience and easy disposal.
- Amenable to large-scale and high-throughput processing, including automated methods.
- Flexible for use with both centrifugation or vacuum-based systems.
- Biodegradable - Environment friendly - Easy and Safe to use.
- A highly efficient RNA extraction kit comes with a gel stain and fluorescent technology for easier extraction and purification of Genomes.
About Azooka's LifeScience:
Within a very short period, Azooka.life company has positioned a respectable status in the Biology industry with fluorescent dye & stains by endlessly manufacturing and supplying a wide assortment of DNA & RNA Extraction Kit/DNA Isolation Kit/DNA Purification kit/DNA gel stains for Biomolecular Laboratories, Schools, Colleges, and more for research purposes. Call Today for more info.
Our Range of Top Seller DNA & RNA Extraction Kits for Sale:
TINTO RANG STAIN SERIES - Tinto rang DNA Gel Stain Academics - Tinto rang DNA Gel Stain 10000x - Tinto Rang PCR Mastermix with Standard Taq DNA polymerase - Tinto Rang Hot Start PCR Mastermix - Tinto Rang High Fidelity Phusion Mastermix, ANO CELL STAIN SERIES - ANO Mitosis Teaching Kit - ANO Yeast Staining Solution, and more.
Book your Free Test Samples for free. Limited period offer. Order your DNA extraction kit Immediately. The best price is guaranteed. Hurry up!
Conclusion:
This is a period of the extraordinary demand for coronavirus testing workflows and other related total RNA Extraction kits. We at Azooka's LifeScience DNA & RNA Extraction kits provider in India, we are doing everything we can to ramp up productions and expanded the capacities at our manufacturing sites in India dramatically.
Thus, the Sales of RNA extraction kits, and other COVID-19 related products, have insulated suppliers that have a strong emphasis in their product mixes from the brunt of COVID-19's economic impact.
If you're interested in more such RNA and DNA extraction process or other related stuff, please feel free to visit us at Azooka.life. If you like this post, like us and share your feeling in the below comment section. Happy LifeScience Research!
More contact details:
Website: https://www.azooka.life
Products : https://azooka.life/shop
Contact number : +919108424562
April 26th every year marks the celebration of World Intellectual Property Day or World IP Day, and its theme for this year is “Innovate for a Green Future.https://www.kashishworld.com/blog/how-can-ip-be-a-solution-in-situations-of-crisis-like-the-covid-19-pandemic/
Coronavirus knocked on our doors and the first thing that saw its adverse effect was our corporate offices.
People started falling ill and dropping out of offices.
Lockdown was initiated and many people had to leave work.
But is that a long-term solution?Nope!By cleaning and keeping your office spotless you will just acquire an aesthetic beauty but what about infections.
For that, we need to take certain steps to make our offices germ-proof.
Here, are some of the best ways to help you with keeping your workplace employee-friendly.
The COVID19 times have taught us many things and the remote work culture comes with a new experience.
So, make the most of this time by making efficient use of these tools.
Pick your favorite and get started!
According to the new market research report “COVID-19 impact on Medical Supplies Market by Type (Intubations, Personal Protective Equipment, Infusion, Radiology, Wound Care Supplies), End User (Hospitals, Clinics) – Global Forecast” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The COVID-19 impact on the global medical supplies market is expected to reach USD ~100 billion by 2021 from an estimated value of USD ~78 billion in 2019, growing at a CAGR of ~13.4% during the forecast period.Growth Boosting Factors:Growing awareness for environmental & personal hygiene leading to rising demand of disinfectantsIncreasing number of emergency centers, hospital settings and ICUs during the PandemicIncreasing need of healthcare workers in hospitals and government camps & surveysIncreased demand of PPE kits and n95 masks globallyIncreasing demand of ventilation supplies for effective management of critical COVID-19 patientsIncreasing demand of diagnostic supplies for rapid diagnosis of COVID-19Browse 97 market data Tables and 20 Figures spread through 150 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158189339Market Segmentation in Detailed:Based on type, the medical supplies market is segmented into intubation and ventilation supplies, disinfectant, personal protective equipment, diagnostic supplies, sterilization supplies, infusion and injectable supplies, dialysis supplies, wound care supplies, radiology supplies, and other medical supplies.
The disinfectant segment is expected to grow at the highest CAGR during the forecast period.Based on end users, the market is segmented into hospitals, clinics, and other end-users.
The hospital segment is expected to grow at the highest CAGR owing to increasing demand for hospital beds and intensive care units in countries with the increasing incidence of COVID-19, increasing demand for specialized staff such as infectious disease experts providers, respiratory therapists, and physicians and nurses who can provide intensive and critical care, increased consumption of personnel protective equipment within the hospital premises; and the increasing support from government and non-government organization to combat with COVID-19 are the major factors driving the demand and uptake of medical supplies in hospitals growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158189339North America accounted for the largest share of the medical supplies market in 2020, followed by Europe.
The large share of this region is attributed mainly to a high number of positive COVID-19 cases and deaths in the US, a strong healthcare system, and the presence of many large hospitals.
Moreover, a large number of major global players are based in the US, owing to which the US can easily manufacture these devices.The prominent players in the medical supplies market are Medtronic plc (Ireland), Cardinal Health, Inc. (US), Becton, Dickson and Company (US), Johnson & Johnson (US), and B. Braun Melsungen AG (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), STERIS Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Smith & Nephew (U.K.), Mölnlycke Health Care AB (Sweden), among others.
In the latest coronavirus vaccine latest update, the US-based biotech company Moderna released new data on Monday which conclusively strengthens its case for the covid-19 vaccine.
The study stated that the moderna vaccine is 94% effective, and causes the human immune system to produce potent antibodies that endure for at least three months.Moderna Inc said that it expects between 100 million to 125 million doses of its experimental covid-19 vaccine available globally in the first quarter of 2021, in this latest covid-19 vaccine update USA.
The company added that around 85 million to 100 million of those doses would be available in the United States, while 15 million to 25 million available outside the country.The first-quarter doses are within the 500 million to up to 1 billion doses the company expects to manufacture in 2021, as per the covid-19 vaccine tracker.The vaccine, mRNA-1273, achieved high levels of binding and neutralizing antibodies in its test subjects.
Although these high levels of antibodies produced due to this covid-19 vaccine declined slightly over time, by introducing a booster vaccination the levels could be maintained high, for up to three months in all participants.The COVID-19 vaccine race:The Moderna vaccine built on the company’s previously reported findings, based on its study of about 30,000 volunteers.
In the study where both placebo and active shots were given to volunteers, only 11 of the active volunteers reported cases as opposed to the 185 cases in the placebo team.In other covid-19 vaccine news – Pfizer, which has developed a similar vaccine, reported similar findings.
Both Moderna and Pfizer vaccine showed promise in preventing severe cases.Based on these findings and the analysis of the vaccine’s safety and side-effects, Moderna has submitted an application for emergency use authorization to the food and drug administration(FDA).Pfizer applied for the same for its covid-19 vaccine on November 9.
